Profound Medical Corp. (PROF)

$7.49

+0.20 (+2.74%)
Rating:
Recommendation:
-
Symbol PROF
Price $7.49
Beta 1.514
Volume Avg. 0.04M
Market Cap 155.638M
Shares () -
52 Week Range 6.09-18.26
1y Target Est -
DCF Unlevered PROF DCF ->
DCF Levered PROF LDCF ->
ROE -37.74% Strong Sell
ROA -39.13% Strong Sell
Operating Margin -
Debt / Equity 7.80% Neutral
P/E -
P/B 2.09 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PROF news


Dr. Arun Swarup Menawat
Healthcare
Medical Devices
NASDAQ Capital Market

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.